Phase II Panitumumab-IRDye800 in Head & Neck Cancer
Condition(s):Head and Neck CancerLast Updated:December 22, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Head and Neck CancerLast Updated:December 22, 2023Recruiting
Condition(s):Colorectal CancerLast Updated:July 31, 2019Completed
Condition(s):Colorectal CancerLast Updated:May 16, 2017Completed
Condition(s):Advanced or Recurrent Colorectal CancerLast Updated:April 6, 2017Completed
Condition(s):Head and Neck CancerLast Updated:April 16, 2019Completed
Condition(s):Solid TumorsLast Updated:May 18, 2016Completed
Condition(s):Head-and-neck Squamous Cell CarcinomaLast Updated:March 4, 2024Not yet recruiting
Condition(s):Colorectal CancerLast Updated:November 27, 2023Recruiting
Condition(s):Carcinoma, Squamous CellLast Updated:August 30, 2010Unknown status
Condition(s):CancerLast Updated:December 16, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.